You have 9 free searches left this month | for more free features.

extensive stage small cell lung cancer

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Extensive-stage Small-cell Lung Cancer, Liver Metastases Trial in Los Angeles, Ann Arbor (Bevacizumab)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Liver Metastases
  • Los Angeles, California
  • +2 more
Oct 18, 2022

Small Cell Lung Cancer Trial in Changsha (IBI-322 Plus Lenvatinib)

Not yet recruiting
  • Small Cell Lung Cancer
  • IBI-322 Plus Lenvatinib
  • Changsha, Hunan, China
    Hunan Cancer hospital
Jul 14, 2022

Small Cell Lung Cancer Extensive Stage Trial (Pembrolizumab, Plinabulin plus Etoposide and Platinum)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Pembrolizumab, Plinabulin plus Etoposide and Platinum
  • (no location specified)
Feb 15, 2023

Extensive-stage Small-cell Lung Cancer Trial in China (serplulimab, Cisplatin, Carboplatin)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Shantou, Guangdong, China
  • +6 more
Mar 1, 2023

Recurrent Extensive Stage Small Cell Lung Carcinoma, Refractory Extensive Stage Small Cell Lung Carcinoma Trial in United States

Active, not recruiting
  • Recurrent Extensive Stage Small Cell Lung Carcinoma
  • Refractory Extensive Stage Small Cell Lung Carcinoma
  • Bakersfield, California
  • +5 more
Jan 5, 2023

Extensive Stage Small Cell Lung Cancer Trial in Shanghai (HLX10, carboplatin and etoposide, )

Active, not recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Shanghai, China
  • +5 more
Sep 28, 2022

Extensive-stage Small Cell Lung Cancer Trial in Changsha (Radiation Therapy)

Completed
  • Extensive-stage Small Cell Lung Cancer
  • Radiation Therapy
  • Changsha, Hunan, China
  • +1 more
Jun 10, 2022

Extensive Stage Small Cell Lung Cancer Trial in Chicago, Indianapolis, Iowa City (Cisplatin, Carboplatin, Etoposide)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Chicago, Illinois
  • +2 more
Jul 1, 2022

Carcinoma, Small Cell Lung Trial in China (Atezolizumab, Cisplatin, Carboplatin)

Active, not recruiting
  • Carcinoma, Small Cell Lung
  • Beijing City, China
  • +7 more
Nov 24, 2022

Small Cell Lung Cancer Trial (SC0245, Irinotecan)

Not yet recruiting
  • Small Cell Lung Cancer
  • (no location specified)
Feb 7, 2023

SCLC,Extensive Stage Trial in Changchun (AK104 IV infusion;Chiauranib oral)

Not yet recruiting
  • SCLC,Extensive Stage
  • AK104 IV infusion;Chiauranib oral
  • Changchun, Jilin, China
    Jilin Province Cancer Hospital
Aug 16, 2022

EvaluatioN of durvALumab Utilization and Effectiveness for First

Recruiting
  • Small Cell Lung Carcinoma
  • Angers, France
  • +24 more
Jan 12, 2023

Extensive-stage Small-cell Lung Cancer Trial in Haikou (Trilaciclib)

Active, not recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Haikou, Hainan, China
    Hainan General Hospital
Jun 13, 2022

Small-cell Lung Cancer, Extensive-stage Small-cell Lung Cancer, Lung Cancer Trial (Ablative Radiation, Durvalumab, Etoposide)

Not yet recruiting
  • Small-cell Lung Cancer
  • +2 more
  • Ablative Radiation
  • +3 more
  • (no location specified)
Mar 11, 2022

Platinum-Resistant Lung Small Cell Carcinoma, Platinum-Sensitive Lung Small Cell Carcinoma, Recurrent Extensive Stage Lung Small

Recruiting
  • Platinum-Resistant Lung Small Cell Carcinoma
  • +3 more
  • Durvalumab
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Small-cell Lung Cancer, Brain Metastases Trial in United States (Carboplatin, Etoposide, Atezolizumab)

Active, not recruiting
  • Small-cell Lung Cancer
  • Brain Metastases
  • Duarte, California
  • +5 more
Oct 10, 2022

Extensive Stage Small Cell Lung Cancer

Completed
  • Extensive Stage Small Cell Lung Cancer
  • First line EC/EP+Atezolizumab
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Jan 22, 2022

Extensive Stage Small Cell Lung Cancer

Completed
  • Extensive Stage Small Cell Lung Cancer
  • First line EC/EP+Atezolizumab
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Jan 22, 2022

Simultaneous Liver Metastases Extensive Stage Small Cell Lung

Completed
  • Extensive Stage Small Cell Lung Cancer
  • First line EC/EP+Atezolizumab
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Jan 22, 2022

SCLC Trial in Shanghai (Carboplatin, Cisplatin, Etoposide)

Active, not recruiting
  • SCLC
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Jul 18, 2022

Carcinoma, Small Cell Trial in Japan

Active, not recruiting
  • Carcinoma, Small Cell
    • Aichi, Japan
    • +29 more
    Dec 6, 2022

    SCLC Trial (PM8002, Platinum, Atezolizumab)

    Not yet recruiting
    • SCLC
    • (no location specified)
    May 4, 2023

    Small Cell Lung Carcinoma, Neuroendocrine Tumors Trial (BI 764532)

    Not yet recruiting
    • Small Cell Lung Carcinoma
    • Neuroendocrine Neoplasms
    • BI 764532
    • (no location specified)
    May 22, 2023

    Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Atlanta (Lurbinectedin, Palliative Radiation

    Not yet recruiting
    • Extensive Stage Lung Small Cell Carcinoma
    • Stage IV Lung Cancer AJCC v8
    • Atlanta, Georgia
    • +2 more
    Apr 12, 2022

    Small Cell Lung Cancer Extensive Stage Trial in Spain (Lenvatinib, Pembrolizumab, Etoposide)

    Recruiting
    • Small Cell Lung Cancer Extensive Stage
    • Badalona, Barcelona, Spain
    • +17 more
    Jan 26, 2023